In an attempt to identify new prognostic markers, we performed fluorescence in situ hybridization (FISH) ploidy analysis of tumor tissue from patients with a targeted stage and histological grade of prostate carcinoma. We identified all 227 patients from the Mayo Clinic radical prostatectomy data base who had a high histological grade pathological stage C (pT3N0M0) tumor removed between 1966 and 1987. After histological review of the paraffin-embedded specimen blocks, 181 cases were suitable for FISH analysis using chromosome enumeration probes for chromosomes 7, 8, 10, 12, X, and Y. FISH detected 80 (44%) diploid, 22 (12%) tetraploid, and 79 (44%) aneuploid tumors. The common aneusomies were of chromosomes 7 and 8, which were present in 51 (28%) and 46 (25%) tumors, respectively. Aneusomies of chromosomes 10, 12, X, and Y were observed in 11 (6%), 15 (8%) 12 (7%) and 16 (9%) tumors, respectively. FISH aneuploid tumors showed a trend of more frequent systemic prostate cancer progression than nonaneuploid tumors (P = 0.060). For individual chromosome anomalies, gains of chromosome 8, aneusomy of chromosome 8, and aneusomy of chromosome Y correlated highly with systemic cancer progression (P = 0.006, 0.013, and 0.021, respectively). Gains of chromosome Y and aneusomy of chromosome Y were associated with an increased prostate cancer death rate (P < 0.001 for both). Multivariate analysis showed that gains of chromosome 8 and aneusomy of chromosome Y were significant independent "predictors" of systemic cancer progression (P = 0.008) and cancer death (P < 0.001), respectively. These results demonstrate that aneuploidy and specific aneusomies detected by FISH are potential markers for a poor prognosis in histological high-grade pathological stage C (pT3N0M0) prostate carcinoma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Background: Copy number variation (CNV) is a class of genomic Structural Variation (SV) that underlie genomic disorders and can have profound implications for health. Short-read genome sequencing (sr-GS) enables CNV calling for genomic intervals of variable size and across multiple phenotypes. However, unresolved challenges include an overwhelming number of false-positive calls due to systematic biases from non-uniform read coverage and collapsed calls resulting from the abundance of paralogous segments and repetitive elements in the human genome.
View Article and Find Full Text PDFGenomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32.
Eur J Hum Genet
September 2024
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Article Synopsis
- Despite research, many neurodevelopmental disorders remain unexplained; our study focuses on a female patient with specific genetic anomalies and brain abnormalities.
- Genomic analysis revealed a complex chromosomal rearrangement involving chromosomes 5, 18, and additional material from chromosome 2.
- The findings highlight the importance of using various genomic technologies to explore complex genetic disorders and improve understanding of their mechanisms.
Family case of Potocki-Lupski syndrome.
Mol Cytogenet
March 2024
Budgetary Institution of KHMAO-Yugra Surgut Regional Clinical Center for Maternity and Childhood Protection, Medical Genetic Counseling Service, Surgut, Russian Federation.
Background: Potocki-Lupski syndrome (PTLS, OMIM # 610883) is a rare genetic developmental disorder resulting from a partial heterozygous microduplication at chromosome 17p11.2. The condition is characterized by a wide variability of clinical expression, which can make its clinical and molecular diagnosis challenging.
View Article and Find Full Text PDFArticle Synopsis
- This study examined a female patient with a neurodevelopmental disorder (NDD) and identified complex genetic alterations including a terminal loss on chromosome 5 and a gain on chromosome 18, despite her parents having normal genetic copies of these chromosomes.
- The researchers discovered an unbalanced translocation between chromosomes 5 and 18, with additional genetic material from chromosome 2, indicating a complex chromosomal rearrangement (CCR).
- The findings highlight the necessity of using different genomic technologies to investigate the genetic basis of complicated NDD cases and enhance understanding of genetic disorders.
Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects.
APMIS
October 2023
Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA.
Article Synopsis
- - Bronchial squamous carcinoma in situ (CIS) is a precursor to invasive carcinoma, and a study from 1992 to 2016 examined its prevalence, molecular markers, and outcomes among affected individuals.
- - Out of 31 CIS cases, 22 were found alongside invasive carcinomas, with some invasive tumors being undetectable through imaging; CIS can sometimes spread to other lung areas or transform into invasive cancer.
- - Although isolated CIS can regress, it often accompanies invasive tumors, and genetic findings, such as TP53 mutations and chromosomal changes, may help understand the progression of these lesions in the airways.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!